57.2. For the purpose of promoting optimal use of medications, the council may, in particular,
(1) engage in or support procedures for the review of the use of medications ;
(2) propose, or contribute to the development and implementation of, training, information and awareness strategies to improve drug prescribing and dispensing practices in cooperation and in conjunction with the various intervenors, including health services and social services institutions ;
(3) make recommendations to the various intervenors and to health care professionals in order to improve the use of medications, without encroaching upon their respective responsibilities ;
(4) propose or contribute to the development and implementation of public information and awareness strategies ; and
(5) see to the assessment of problems related to the use of medications and the implementation of measures to prevent and correct such problems.
To that end, the council shall consult the Collège des médecins du Québec and the Ordre des pharmaciens du Québec at least once a year.
The council may, on request, obtain from the Board the following information, in non-nominative form as concerns the person to whom a medication was provided :
(1) a sequential number ;
(2) the person’s date of birth and sex ;
(3) the profession and the specialty, if any, of the prescriber and the first three characters of the postal code of the prescriber’s professional address ;
(4) the name of the medication, the quantity dispensed and the therapeutic intent, if specified ;
(5) the prescription number and type, whether the prescription is a new prescription or a renewal, whether the prescription is a written or verbal prescription, the number of renewals authorized or the date of expiry, the dosage and the duration of the treatment ; and
(6) the date on which the service was dispensed.
In addition to the information listed in the third paragraph and provided the physician or pharmacist concerned has not objected thereto, the council may, on request, obtain the following information from the Board for the sole purpose of sending the physician or pharmacist an individual practice profile for informational purposes :
(1) the pharmacy number and the dispensing pharmacist’s number ; and
(2) the prescriber’s number or, in the absence thereof, the prescriber’s surname and the initial of the prescriber’s given name.
In addition, the council may, on request, obtain from the Board any other data in non-nominative form that is necessary to promote optimal use of medications.
2002, c. 27, s. 20; 2005, c. 40, s. 20.